TapewireFind a company

person · Reporting owner

Anand Kapila K

Disclosed activity across 4 companies

Tapewire entity
32612
SEC CIK
0001679166

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
ESH Hospitality, Inc.NONE · Entity 16193DirectorJune 16, 2021June 21, 2021
Elanco Animal Health IncELAN · Entity 3457DirectorSeptember 30, 2026October 02, 2026
OMEGA HEALTHCARE INVESTORS INCOHI · Entity 3362DirectorJune 05, 2026June 09, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

ESH Hospitality, Inc.

Report date June 16, 2021 · Filed June 21, 2021

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Paired SharesSEC Table I · non-derivativeDirect0 Reported balance After 2021-06-16 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2021-06-16 · Disposition to issuer · Disposed 41,001 · Balance 0

F1: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. This Form 4 is being filed in connection with the merger ("Merger") of a wholly-owned subsidiary of Eagle Parent Holdings L.P. ("Eagle") with and into the Issuer, pursuant to the terms of the certain Agreement and Plan of Merger, dated as of March 14, 2021 (the "Merger Agreement"), between the Issuer and Eagle. The Merger closed on June 16, 2021.

F2: Each Paired Share held directly or indirectly by the reporting person at the effective time of the Merger was disposed of for $18.75 in cash, pursuant to the terms of the Merger Agreement. This price does not include the special dividend of $1.75 per Paired Share that the reporting person has the right to receive in connection with the consummation of the Merger.

Paired SharesSEC Table I · non-derivativeIndirectSee footnote0 Reported balance After 2021-06-16 transaction · row 2 Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source row

Row 2 · 2021-06-16 · Disposition to issuer · Disposed 1,500 · Balance 0

F1: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. This Form 4 is being filed in connection with the merger ("Merger") of a wholly-owned subsidiary of Eagle Parent Holdings L.P. ("Eagle") with and into the Issuer, pursuant to the terms of the certain Agreement and Plan of Merger, dated as of March 14, 2021 (the "Merger Agreement"), between the Issuer and Eagle. The Merger closed on June 16, 2021.

F2: Each Paired Share held directly or indirectly by the reporting person at the effective time of the Merger was disposed of for $18.75 in cash, pursuant to the terms of the Merger Agreement. This price does not include the special dividend of $1.75 per Paired Share that the reporting person has the right to receive in connection with the consummation of the Merger.

F3: These Paired Shares are held through an individual retirement account for which the reporting person is a fiduciary.

Filing footnotes · ownership attribution and instrument terms

F1: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. This Form 4 is being filed in connection with the merger ("Merger") of a wholly-owned subsidiary of Eagle Parent Holdings L.P. ("Eagle") with and into the Issuer, pursuant to the terms of the certain Agreement and Plan of Merger, dated as of March 14, 2021 (the "Merger Agreement"), between the Issuer and Eagle. The Merger closed on June 16, 2021.

F2: Each Paired Share held directly or indirectly by the reporting person at the effective time of the Merger was disposed of for $18.75 in cash, pursuant to the terms of the Merger Agreement. This price does not include the special dividend of $1.75 per Paired Share that the reporting person has the right to receive in connection with the consummation of the Merger.

F3: These Paired Shares are held through an individual retirement account for which the reporting person is a fiduciary.

Elanco Animal Health Inc

Report date September 30, 2026 · Filed October 02, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Deferred Stock UnitsSEC Table II · derivative / convertible securityDirect10,721.5916 Reported balance After 2026-09-30 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2026-09-30 · Grant · Acquired 642.0277 · Balance 10,721.5916

F1: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $24.61 on September 30, 2026.

Filing footnotes · ownership attribution and instrument terms

F1: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $24.61 on September 30, 2026.

OMEGA HEALTHCARE INVESTORS INC

Report date June 05, 2026 · Filed June 09, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Deferred Stock UnitsSEC Table II · derivative / convertible securityDirect44,992 Reported balance After 2026-06-05 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2026-06-05 · Grant · Acquired 6,205 · Balance 44,992

F1: Units convert into shares of common stock on a one-to-one basis. If the participant so elects, dividends will also be converted into Deferred Stock Units.

F2: These units represent the annual grant of restricted stock elected to be taken as Deferred Stock Units by the reporting person. The units are restricted to transfer and sale until Omega's 2027 Annual Meeting of Shareholders (the "Vesting Date").

F3: These units are restricted from sale and transfer until the Vesting Date. The units will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all defined in such plan.

F4: These units do not expire and will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all as defined in such plan.

Filing footnotes · ownership attribution and instrument terms

F1: Units convert into shares of common stock on a one-to-one basis. If the participant so elects, dividends will also be converted into Deferred Stock Units.

F2: These units represent the annual grant of restricted stock elected to be taken as Deferred Stock Units by the reporting person. The units are restricted to transfer and sale until Omega's 2027 Annual Meeting of Shareholders (the "Vesting Date").

F3: These units are restricted from sale and transfer until the Vesting Date. The units will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all defined in such plan.

F4: These units do not expire and will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all as defined in such plan.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Extended Stay America, Inc.

Report date June 16, 2021 · Filed June 17, 2021

Section 16 reporting ended · disclosed 2021-06-17. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Paired SharesSEC Table I · non-derivativeDirect0 Reported balance After 2021-06-16 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2021-06-16 · Sale · Disposed 41,001 · Balance 0

F1: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit.

F2: All Paired Shares held directly or indirectly by the reporting person were disposed upon completion of the merger ("Merger") of a wholly-owned subsidiary of Eagle Parent Holdings L.P. ("Eagle") with and into the Issuer, effective June 16, 2021. This price does not include the special dividend of $1.75 per Paired Share that the reporting person has the right to receive in connection with the consummation of the Merger.

Paired SharesSEC Table I · non-derivativeIndirectSee footnote0 Reported balance After 2021-06-16 transaction · row 2 Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source row

Row 2 · 2021-06-16 · Sale · Disposed 1,500 · Balance 0

F1: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit.

F2: All Paired Shares held directly or indirectly by the reporting person were disposed upon completion of the merger ("Merger") of a wholly-owned subsidiary of Eagle Parent Holdings L.P. ("Eagle") with and into the Issuer, effective June 16, 2021. This price does not include the special dividend of $1.75 per Paired Share that the reporting person has the right to receive in connection with the consummation of the Merger.

F3: These Paired Shares are held through an individual retirement account for which the reporting person is a fiduciary.

Filing footnotes · ownership attribution and instrument terms

F1: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit.

F2: All Paired Shares held directly or indirectly by the reporting person were disposed upon completion of the merger ("Merger") of a wholly-owned subsidiary of Eagle Parent Holdings L.P. ("Eagle") with and into the Issuer, effective June 16, 2021. This price does not include the special dividend of $1.75 per Paired Share that the reporting person has the right to receive in connection with the consummation of the Merger.

F3: These Paired Shares are held through an individual retirement account for which the reporting person is a fiduciary.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
September 30, 2026 Filed Oct 2, 2026 00:04 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 642.0277 $22.39 $14,375.00
Disclosure

SEC source: 0001679166-26-000013 · form4-10012026_081007.xml · derivative · entry 1

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,721.5916

Underlying: Common Stock · 642.0277 shares

Expires not disclosed

F1 · security: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $24.61 on September 30, 2026.

F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $24.61 on September 30, 2026.

F1 · derivative.exercise_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
June 30, 2026 Filed Jul 2, 2026 20:49 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 584.1121 $24.61 $14,375.00
Disclosure

SEC source: 0001679166-26-000011 · form4-07022026_080714.xml · derivative · entry 1

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,079.5639

Underlying: Common Stock · 584.1121 shares

Expires not disclosed

F1 · security: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $24.61 on June 30, 2026.

F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $24.61 on June 30, 2026.

F1 · derivative.exercise_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
June 05, 2026 Filed Jun 9, 2026 20:15 UTC OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362 GrantDeferred Stock Units · Derivative 6,205 $0.00 $0.00
Disclosure

SEC source: 0001679166-26-000008 · form4-06092026_040624.xml · derivative · entry 1

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,992

Underlying: Common Stock · 6,205 shares

Expires not disclosed

F1 · derivative.exercise_price: Units convert into shares of common stock on a one-to-one basis. If the participant so elects, dividends will also be converted into Deferred Stock Units.

F2 · derivative.exercise_price: These units represent the annual grant of restricted stock elected to be taken as Deferred Stock Units by the reporting person. The units are restricted to transfer and sale until Omega's 2027 Annual Meeting of Shareholders (the "Vesting Date").

F3 · derivative.exercise_date: These units are restricted from sale and transfer until the Vesting Date. The units will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all defined in such plan.

F4 · derivative.expiration_date: These units do not expire and will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all as defined in such plan.

Read SEC document
May 21, 2026 Filed May 26, 2026 20:43 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantCommon Stock 12,196 $0.00 $0.00
Disclosure

SEC source: 0001679166-26-000006 · form4-05262026_080551.xml · nonDerivative · entry 2

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 111,847

F2 · shares: Grant of restricted stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.

Read SEC document
May 21, 2026 Filed May 26, 2026 20:43 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantCommon Stock 4,678 $0.00 $0.00
Disclosure

SEC source: 0001679166-26-000006 · form4-05262026_080551.xml · nonDerivative · entry 1

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,651

F1 · shares: Grant of deferred stock units as a pro-rated annual equity award to each of the non-employee members of the Issuer's Board of Directors.

Read SEC document
March 31, 2026 Filed Apr 2, 2026 20:02 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 600.7104 $23.93 $14,375.00
Disclosure

SEC source: 0001679166-26-000004 · form4-04022026_080421.xml · derivative · entry 1

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,495.4518

Underlying: Common Stock · 600.7104 shares

Expires not disclosed

F1 · security: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $23.93 on March 31, 2026.

F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $23.93 on March 31, 2026.

F1 · derivative.exercise_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
December 31, 2025 Filed Jan 5, 2026 22:35 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 381.1312 $22.63 $8,625.00
Disclosure

SEC source: 0001679166-26-000002 · form4-01052026_100159.xml · derivative · entry 1

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,894.7414

Underlying: Common Stock · 381.1312 shares

Expires not disclosed

F1 · security: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $22.63 on December 31, 2025.

F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $22.63 on December 31, 2025.

F1 · derivative.exercise_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
November 28, 2025 Filed Dec 2, 2025 22:12 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantCommon Stock 10,314 $0.00 $0.00
Disclosure

SEC source: 0001679166-25-000007 · form4-12022025_101219.xml · nonDerivative · entry 1

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,973

F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.

Read SEC document
September 30, 2025 Filed Oct 2, 2025 21:20 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 428.2522 $20.14 $8,625.00
Disclosure

SEC source: 0001679166-25-000005 · form4-10022025_091028.xml · derivative · entry 1

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,513.6102

Underlying: Common Stock · 428.2522 shares

Expires not disclosed

F1 · security: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $20.14 on September 30, 2025.

F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $20.14 on September 30, 2025.

F1 · derivative.exercise_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
June 30, 2025 Filed Jul 2, 2025 20:16 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 603.9916 $14.28 $8,625.00
Disclosure

SEC source: 0001415889-25-019033 · form4-07022025_080721.xml · derivative · entry 1

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,085.358

Underlying: Common Stock · 603.9916 shares

Expires not disclosed

F1 · security: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $14.28 on June 30, 2025.

F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $14.28 on June 30, 2025.

F1 · derivative.exercise_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
June 06, 2025 Filed Jun 10, 2025 20:05 UTC OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362 GrantDeferred Stock Units · Derivative 6,150 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-016462 · form4-06102025_040615.xml · derivative · entry 1

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,405

Underlying: Common Stock · 6,150 shares

Expires not disclosed

F1 · derivative.exercise_price: Units convert into shares of common stock on a one-to-one basis. If the participant so elects, dividends will also be converted into Deferred Stock Units.

F2 · derivative.exercise_price: These units represent the annual grant of restricted stock elected to be taken as Deferred Stock Units by the reporting person. The units are restricted to transfer and sale until Omega's 2026 Annual Meeting of Shareholders (the "Vesting Date").

F3 · derivative.exercise_date: These units are restricted from sale and transfer until the Vesting Date. The units will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all defined in such plan.

F4 · derivative.expiration_date: These units do not expire and will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all as defined in such plan.

Read SEC document
March 31, 2025 Filed Apr 2, 2025 21:41 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 821.4286 $10.50 $8,625.00
Disclosure

SEC source: 0001415889-25-009744 · form4-04022025_090439.xml · derivative · entry 1

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,481.3664

Underlying: Common Stock · 821.4286 shares

Expires not disclosed

F1 · security: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $10.50 on March 31, 2025.

F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $10.50 on March 31, 2025.

F1 · derivative.exercise_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
November 29, 2024 Filed Dec 3, 2024 22:11 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantCommon Stock 18,169 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-028151 · form4-12032024_101223.xml · nonDerivative · entry 1

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 84,659

F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.

Read SEC document
June 07, 2024 Filed Jun 11, 2024 19:54 UTC OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362 GrantDeferred Stock Units · Derivative 5,756 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-016332 · form4-06112024_070654.xml · derivative · entry 1

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,772

Underlying: Common Stock · 5,756 shares

Expires not disclosed

F1 · derivative.exercise_price: Units convert into shares of common stock on a one-to-one basis. If the participant so elects, dividends will also be converted into Deferred Stock Units.

F2 · derivative.exercise_price: These units represent the annual grant of restricted stock elected to be taken as Deferred Stock Units by the reporting person. The units are restricted to transfer and sale until Omega's 2025 Annual Meeting of Shareholders. (the "Vesting Date").

F3 · derivative.exercise_date: These units are restricted from sale and transfer until the Vesting Date. The units will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all defined in such plan.

F4 · derivative.expiration_date: These units do not expire and will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all as defined in such plan.

Read SEC document
December 29, 2023 Filed Jan 3, 2024 21:49 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 964.7651 $14.90 $14,375.00
Disclosure

SEC source: 0001415889-24-000323 · form4-01032024_090123.xml · derivative · entry 1

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,659.9378

Underlying: Common Stock · 964.7651 shares

Expires not disclosed

F1 · security: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $14.90 on December 29, 2023.

F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $14.90 on December 29, 2023.

F1 · derivative.exercise_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
November 30, 2023 Filed Dec 4, 2023 22:34 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantCommon Stock 20,374 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-015783 · form4-12042023_101211.xml · nonDerivative · entry 1

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,490

F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.

Read SEC document
September 29, 2023 Filed Oct 3, 2023 20:40 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 1,278.9146 $11.24 $14,375.00
Disclosure

SEC source: 0001415889-23-013887 · form4-10032023_081002.xml · derivative · entry 1

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,695.1727

Underlying: Common Stock · 1,278.9146 shares

Expires not disclosed

F1 · security: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $11.24 on September 29, 2023.

F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $11.24 on September 29, 2023.

F1 · derivative.exercise_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
June 30, 2023 Filed Jul 5, 2023 21:12 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 1,428.9264 $10.06 $14,375.00
Disclosure

SEC source: 0001415889-23-010788 · form4-07052023_090706.xml · derivative · entry 2

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,416.2581

Underlying: Common Stock · 1,428.9264 shares

Expires not disclosed

F1 · security: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F4 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $10.06 on June 30, 2023.

F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F4 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $10.06 on June 30, 2023.

F1 · derivative.exercise_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
June 05, 2023 Filed Jun 7, 2023 21:35 UTC OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362 GrantDeferred Stock Units · Derivative 7,076 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-009389 · form4-06072023_090608.xml · derivative · entry 1

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,721

Underlying: Common Stock · 7,076 shares

Expires not disclosed

F1 · derivative.exercise_price: Units convert into shares of common stock on a one-to-one basis. If the participant so elects, dividends will also be converted into Deferred Stock Units.

F2 · derivative.exercise_price: These units represent the annual grant of restricted stock elected to be taken as Deferred Stock Units by the reporting person. The units are restricted to transfer and sale until Omega's 2024 Annual Meeting of Shareholders. (the "Vesting Date").

F3 · derivative.exercise_date: These units are restricted from sale and transfer until the Vesting Date. The units will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all defined in such plan.

F4 · derivative.expiration_date: These units do not expire and will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all as defined in such plan.

F5 · balance_after: Includes deferred shares acquired via dividend reinvestment.

Read SEC document
March 31, 2023 Filed Jul 5, 2023 21:12 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 1,529.2553 $9.40 $14,375.00
Disclosure

SEC source: 0001415889-23-010788 · form4-07052023_090706.xml · derivative · entry 1

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,987.3317

Underlying: Common Stock · 1,529.2553 shares

Expires not disclosed

F1 · security: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $9.40 on March 31, 2023.

F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $9.40 on March 31, 2023.

F1 · derivative.exercise_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
November 30, 2022 Filed Dec 2, 2022 22:06 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantCommon Stock 18,649 $0.00 $0.00
Disclosure

SEC source: 0001415889-22-011974 · form4-12022022_101211.xml · nonDerivative · entry 1

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,116

F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.

Read SEC document
June 03, 2022 Filed Jun 7, 2022 18:43 UTC OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362 GrantDeferred Stock Units · Derivative 9,237 $0.00 $0.00
Disclosure

SEC source: 0001415889-22-006194 · form4-06072022_110645.xml · derivative · entry 1

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,021

Underlying: Common Stock · 9,237 shares

Expires not disclosed

F1 · derivative.exercise_price: Units convert into shares of common stock on a one-to-one basis. If the participant so elects, dividends will also be converted into Deferred Stock Units.

F2 · shares: These units represent the annual grant of restricted stock elected to be taken as Deferred Stock Units by the reporting person. The units are restricted as to transfer and sale until Omega's 2023 Annual Meeting of Shareholders (the "Vesting Date").

F3 · derivative.exercise_date: These units are restricted as to sale and transfer until the Vesting Date. The units will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all as defined in such plan.

F4 · derivative.expiration_date: These units will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all as defined in such plan.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:05 UTC Elanco Animal Health Inc TNC · Entity 3457 PurchaseCommon Stock 1,000 $28.48 $28,479.00
Disclosure

SEC source: 0001415889-22-002283 · form4-03032022_040307.xml · nonDerivative · entry 1

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,467

Read SEC document
December 31, 2021 Filed Jan 4, 2022 22:48 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 168.8397 $28.38 $4,791.67
Disclosure

SEC source: 0001179110-22-000130 · edgar.xml · derivative · entry 1

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,458.0764

Underlying: Common Stock · 168.8397 shares

Expires not disclosed

F1 · security: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $28.38 on December 31, 2021.

F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $28.38 on December 31, 2021.

F1 · derivative.exercise_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
November 30, 2021 Filed Dec 2, 2021 22:15 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 166.7248 $28.74 $4,791.67
Disclosure

SEC source: 0001179110-21-010540 · edgar.xml · derivative · entry 2

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,289.2367

Underlying: Common Stock · 166.7248 shares

Expires not disclosed

F2 · security: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F3 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F4 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $28.74 on November 30, 2021.

F3 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F4 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $28.74 on November 30, 2021.

F2 · derivative.exercise_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · derivative.expiration_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
November 30, 2021 Filed Dec 2, 2021 22:15 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantCommon Stock 7,307 $0.00 $0.00
Disclosure

SEC source: 0001179110-21-010540 · edgar.xml · nonDerivative · entry 1

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,467

F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.

Read SEC document
November 15, 2021 Filed Nov 15, 2021 19:48 UTC OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362 PurchaseCommon Stock 1,000 $28.32 $28,317.60
Disclosure

SEC source: 0001127602-21-029098 · form4.xml · nonDerivative · entry 1

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,676

F1 · shares: The shares were purchased by the reporting person in a single block trade at $28.3176.

Read SEC document
October 29, 2021 Filed Nov 2, 2021 20:28 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 111.5164 $32.88 $3,666.66
Disclosure

SEC source: 0001179110-21-009766 · edgar.xml · derivative · entry 1

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,122.5119

Underlying: Common Stock · 111.5164 shares

Expires not disclosed

F1 · security: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $32.88 on October 29, 2021.

F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $32.88 on October 29, 2021.

F1 · derivative.exercise_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
September 30, 2021 Filed Oct 4, 2021 20:20 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 114.9784 $31.89 $3,666.66
Disclosure

SEC source: 0001179110-21-009151 · edgar.xml · derivative · entry 1

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,010.9955

Underlying: Common Stock · 114.9784 shares

Expires not disclosed

F1 · security: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $31.89 on September 30, 2021.

F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $31.89 on September 30, 2021.

F1 · derivative.exercise_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
August 31, 2021 Filed Sep 2, 2021 20:23 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 109.846 $33.38 $3,666.66
Disclosure

SEC source: 0001235110-21-000028 · edgar.xml · derivative · entry 1

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 896.0171

Underlying: Common Stock · 109.846 shares

Expires not disclosed

F1 · security: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $33.38 on August 31, 2021.

F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $33.38 on August 31, 2021.

F1 · derivative.exercise_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
July 30, 2021 Filed Aug 3, 2021 20:39 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 100.5391 $36.37 $3,656.61
Disclosure

SEC source: 0000950138-21-000400 · edgar.xml · derivative · entry 7

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 786.1711

Underlying: Common Stock · 100.5391 shares

Expires not disclosed

F1 · security: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F9 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $36.37 on July 30, 2021.

F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F9 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $36.37 on July 30, 2021.

F1 · derivative.exercise_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
July 22, 2021 Filed Jul 26, 2021 19:11 UTC OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362 GrantDeferred Stock Units · Derivative 1,014 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-022494 · form4.xml · derivative · entry 1

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,122

Underlying: Common Stock · 1,014 shares

Expires not disclosed

F1 · derivative.exercise_price: Units convert into shares of common stock on a 1 for 1 basis. If the participant so elects, dividends will also be converted into Deferred Stock Units.

F2 · shares: These units represent an adjustment to the 2021 annual grant in accordance with a change in Omega's Director compensation. The reporting person has elected their grant be taken as Deferred Stock Units. The units are restricted as to transfer and sale until Omega's 2022 Annual Meeting of Shareholders (the "Vesting Date").

F3 · derivative.exercise_date: These units are restricted as to sale and transfer until the Vesting Date. The units will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all as defined in such plan.

F4 · derivative.expiration_date: These units will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all as defined in such plan.

Read SEC document
June 30, 2021 Filed Aug 3, 2021 20:39 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 105.6979 $34.69 $3,666.66
Disclosure

SEC source: 0000950138-21-000400 · edgar.xml · derivative · entry 6

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 685.632

Underlying: Common Stock · 105.6979 shares

Expires not disclosed

F1 · security: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F8 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $34.69 on June 30, 2021.

F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F8 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $34.69 on June 30, 2021.

F1 · derivative.exercise_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
June 16, 2021 Filed Jun 17, 2021 21:59 UTC Extended Stay America, Inc. STAY · Entity 16197 SalePaired Shares 1,500 $18.75 $28,125.00
Disclosure

SEC source: 0000895345-21-000589 · form4.xml · nonDerivative · entry 2

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

F1 · security: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit.

F2 · price: All Paired Shares held directly or indirectly by the reporting person were disposed upon completion of the merger ("Merger") of a wholly-owned subsidiary of Eagle Parent Holdings L.P. ("Eagle") with and into the Issuer, effective June 16, 2021. This price does not include the special dividend of $1.75 per Paired Share that the reporting person has the right to receive in connection with the consummation of the Merger.

F3 · ownership.nature: These Paired Shares are held through an individual retirement account for which the reporting person is a fiduciary.

Read SEC document
June 16, 2021 Filed Jun 17, 2021 21:59 UTC Extended Stay America, Inc. STAY · Entity 16197 SalePaired Shares 41,001 $18.75 $768,768.75
Disclosure

SEC source: 0000895345-21-000589 · form4.xml · nonDerivative · entry 1

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · security: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit.

F2 · price: All Paired Shares held directly or indirectly by the reporting person were disposed upon completion of the merger ("Merger") of a wholly-owned subsidiary of Eagle Parent Holdings L.P. ("Eagle") with and into the Issuer, effective June 16, 2021. This price does not include the special dividend of $1.75 per Paired Share that the reporting person has the right to receive in connection with the consummation of the Merger.

Read SEC document
June 16, 2021 Filed Jun 21, 2021 17:32 UTC ESH Hospitality, Inc. NONE · Entity 16193 Disposition to issuerPaired Shares 1,500 $18.75 $28,125.00
Disclosure

SEC source: 0000895345-21-000606 · form4.xml · nonDerivative · entry 2

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

F1 · security: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. This Form 4 is being filed in connection with the merger ("Merger") of a wholly-owned subsidiary of Eagle Parent Holdings L.P. ("Eagle") with and into the Issuer, pursuant to the terms of the certain Agreement and Plan of Merger, dated as of March 14, 2021 (the "Merger Agreement"), between the Issuer and Eagle. The Merger closed on June 16, 2021.

F2 · kind: Each Paired Share held directly or indirectly by the reporting person at the effective time of the Merger was disposed of for $18.75 in cash, pursuant to the terms of the Merger Agreement. This price does not include the special dividend of $1.75 per Paired Share that the reporting person has the right to receive in connection with the consummation of the Merger.

F2 · price: Each Paired Share held directly or indirectly by the reporting person at the effective time of the Merger was disposed of for $18.75 in cash, pursuant to the terms of the Merger Agreement. This price does not include the special dividend of $1.75 per Paired Share that the reporting person has the right to receive in connection with the consummation of the Merger.

F3 · ownership.nature: These Paired Shares are held through an individual retirement account for which the reporting person is a fiduciary.

Read SEC document
June 16, 2021 Filed Jun 21, 2021 17:32 UTC ESH Hospitality, Inc. NONE · Entity 16193 Disposition to issuerPaired Shares 41,001 $18.75 $768,768.75
Disclosure

SEC source: 0000895345-21-000606 · form4.xml · nonDerivative · entry 1

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · security: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. This Form 4 is being filed in connection with the merger ("Merger") of a wholly-owned subsidiary of Eagle Parent Holdings L.P. ("Eagle") with and into the Issuer, pursuant to the terms of the certain Agreement and Plan of Merger, dated as of March 14, 2021 (the "Merger Agreement"), between the Issuer and Eagle. The Merger closed on June 16, 2021.

F2 · kind: Each Paired Share held directly or indirectly by the reporting person at the effective time of the Merger was disposed of for $18.75 in cash, pursuant to the terms of the Merger Agreement. This price does not include the special dividend of $1.75 per Paired Share that the reporting person has the right to receive in connection with the consummation of the Merger.

F2 · price: Each Paired Share held directly or indirectly by the reporting person at the effective time of the Merger was disposed of for $18.75 in cash, pursuant to the terms of the Merger Agreement. This price does not include the special dividend of $1.75 per Paired Share that the reporting person has the right to receive in connection with the consummation of the Merger.

Read SEC document
June 07, 2021 Filed Jun 9, 2021 17:34 UTC OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362 GrantDeferred Stock Units · Derivative 6,108 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-019483 · form4.xml · derivative · entry 1

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,108

Underlying: Common Stock · 6,108 shares

Expires not disclosed

F1 · derivative.exercise_price: Units convert into shares of common stock on a 1 for 1 basis. If the participant so elects, dividends will also be converted into Deferred Stock Units.

F2 · shares: These units represent the annual grant of restricted stock elected to be taken as Deferred Stock Units by the reporting person. The units are restricted as to transfer and sale until Omega's 2022 Annual Meeting of Shareholders (the "Vesting Date").

F3 · derivative.exercise_date: These units are restricted as to sale and transfer until the Vesting Date. The units will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all as defined in such plan.

F4 · derivative.expiration_date: These units will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all as defined in such plan.

Read SEC document
May 28, 2021 Filed Aug 3, 2021 20:39 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 101.9083 $35.98 $3,666.66
Disclosure

SEC source: 0000950138-21-000400 · edgar.xml · derivative · entry 5

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 579.9341

Underlying: Common Stock · 101.9083 shares

Expires not disclosed

F1 · security: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F7 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $35.98 on May 28, 2021.

F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F7 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $35.98 on May 28, 2021.

F1 · derivative.exercise_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
April 30, 2021 Filed Aug 3, 2021 20:39 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 115.631 $31.71 $3,666.66
Disclosure

SEC source: 0000950138-21-000400 · edgar.xml · derivative · entry 4

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 478.0258

Underlying: Common Stock · 115.631 shares

Expires not disclosed

F1 · security: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F6 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $31.71 on April 30, 2021.

F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F6 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $31.71 on April 30, 2021.

F1 · derivative.exercise_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
March 31, 2021 Filed Aug 3, 2021 20:39 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 124.5046 $29.45 $3,666.66
Disclosure

SEC source: 0000950138-21-000400 · edgar.xml · derivative · entry 3

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 362.3948

Underlying: Common Stock · 124.5046 shares

Expires not disclosed

F1 · security: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F5 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $29.45 on March 31, 2021.

F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F5 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $29.45 on March 31, 2021.

F1 · derivative.exercise_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
February 26, 2021 Filed Aug 3, 2021 20:39 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 111.5843 $32.86 $3,666.66
Disclosure

SEC source: 0000950138-21-000400 · edgar.xml · derivative · entry 2

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 237.8902

Underlying: Common Stock · 111.5843 shares

Expires not disclosed

F1 · security: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F4 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $32.86 on February 26, 2021.

F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F4 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $32.86 on February 26, 2021.

F1 · derivative.exercise_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
January 29, 2021 Filed Aug 3, 2021 20:39 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 126.3059 $29.03 $3,666.66
Disclosure

SEC source: 0000950138-21-000400 · edgar.xml · derivative · entry 1

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 126.3059

Underlying: Common Stock · 126.3059 shares

Expires not disclosed

F1 · security: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $29.03 on January 29, 2021.

F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $29.03 on January 29, 2021.

F1 · derivative.exercise_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
November 30, 2020 Filed Dec 2, 2020 22:50 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantCommon Stock 5,885 $0.00 $0.00
Disclosure

SEC source: 0000950138-20-000499 · edgar.xml · nonDerivative · entry 1

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,160

F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.

Read SEC document
June 11, 2020 Filed Jun 15, 2020 18:16 UTC OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362 GrantCommon Stock 4,597 $32.63 $150,000.11
Disclosure

SEC source: 0001127602-20-019547 · form4.xml · nonDerivative · entry 1

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,676

F1 · shares: Represents Director compensation via the annual grant of restricted stock that will vest on the date of the Company's 2021 Annual Meeting of shareholders, which is approximately one year from grant date.

Read SEC document
May 28, 2020 Filed May 29, 2020 16:17 UTC ESH Hospitality, Inc. NONE · Entity 16193 GrantPaired Shares 10,918 $0.00 $0.00
Disclosure

SEC source: 0000895345-20-000666 · form4.xml · nonDerivative · entry 1

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,001

F1 · security: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit.

F2 · kind: The reported transaction is an award of Restricted Stock Units in respect of Paired Shares. A Form 4 reflecting the transaction in Paired Shares by the reporting person shown on this Form 4 has been concurrently filed with respect to Extended Stay America, Inc. as issuer. Of the 10,918 Paired Shares acquired in the reported transaction, 5,459 were granted to the reporting person under the Amended and Restated Extended Stay America, Inc. Long-Term Incentive Plan and 5,459 were granted to the reporting person under the Amended and Restated ESH Hospitality, Inc. Long-Term Incentive Plan. Subject to the reporting person's continued service as a director of the issuer through the vesting date, these Restricted Stock Units are scheduled to vest in full on May 28, 2021.

F3 · kind: Vested Restricted Stock Units will be settled in Paired Shares on the September 15th next following the vesting date (or, in any year when the 15th of September falls on a non-business day, the business day immediately prior to such date).

Read SEC document
May 28, 2020 Filed May 29, 2020 16:11 UTC Extended Stay America, Inc. STAY · Entity 16197 GrantPaired Shares 10,918 $0.00 $0.00
Disclosure

SEC source: 0000895345-20-000663 · form4.xml · nonDerivative · entry 1

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,001

F1 · security: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit.

F2 · kind: The reported transaction is an award of Restricted Stock Units in respect of Paired Shares. A Form 4 reflecting the transaction in Paired Shares by the reporting person shown on this Form 4 has been concurrently filed with respect to ESH Hospitality, Inc. as issuer. Of the 10,918 Paired Shares acquired in the reported transaction, 5,459 were granted to the reporting person under the Amended and Restated Extended Stay America, Inc. Long-Term Incentive Plan and 5,459 were granted to the reporting person under the Amended and Restated ESH Hospitality, Inc. Long-Term Incentive Plan. Subject to the reporting person's continued service as a director of the issuer through the vesting date, these Restricted Stock Units are scheduled to vest in full on May 28, 2021.

F3 · kind: Vested Restricted Stock Units will be settled in Paired Shares on the September 15th next following the vesting date (or, in any year when the 15th of September falls on a non-business day, the business day immediately prior to such date).

Read SEC document
March 06, 2020 Filed Mar 9, 2020 09:10 UTC ESH Hospitality, Inc. NONE · Entity 16193 PurchasePaired Shares 1,500 $9.95 $14,925.00
Disclosure

SEC source: 0000895345-20-000295 · form4.xml · nonDerivative · entry 1

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,500

F1 · security: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit.

F2 · ownership.nature: These Paired Shares are held through an individual retirement account for which the reporting person is a fiduciary.

Read SEC document
March 06, 2020 Filed Mar 9, 2020 09:11 UTC Extended Stay America, Inc. STAY · Entity 16197 PurchasePaired Shares 1,500 $9.95 $14,925.00
Disclosure

SEC source: 0000895345-20-000296 · form4.xml · nonDerivative · entry 1

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,500

F1 · security: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit.

F2 · ownership.nature: These Paired Shares are held through an individual retirement account for which the reporting person is a fiduciary.

Read SEC document
March 04, 2020 Filed Mar 6, 2020 21:09 UTC Elanco Animal Health Inc ELAN · Entity 3457 PurchaseCommon Stock 1,000 $26.86 $26,860.00
Disclosure

SEC source: 0000950138-20-000138 · edgar.xml · nonDerivative · entry 1

Anand Kapila K · CIK 0001679166 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,275

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.